Qualification of academic facilities for small-scale automated manufacture of autologous cell-based products
Academic centres, hospitals and small companies, as typical development settings for UK regenerative medicine assets, are significant contributors to the development of autologous cell-based therapies. Often lacking the appropriate funding, quality assurance heritage or specialist regulatory experti...
Saved in:
Main Authors: | Paul Hourd, Amit Chandra, David Alvey, Patrick J. Ginty, Mark McCall, Elizabeth Ratcliffe, Erin Rayment, David Williams |
---|---|
Format: | Default Article |
Published: |
2014
|
Subjects: | |
Online Access: | https://hdl.handle.net/2134/25986 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Manufacturing models permitting roll out/scale out of clinically led autologous cell therapies: regulatory and scientific challenges for comparability
by: Paul Hourd, et al.
Published: (2014) -
A 3D-bioprinting exemplar of the consequences of the regulatory requirements on customised processes
by: Paul Hourd, et al.
Published: (2015) -
A Monte Carlo framework for managing biological variability in manufacture of autologous cell therapy from mesenchymal stromal cells therapies
by: Andrew Picken, et al.
Published: (2020) -
GNVQ, is it for you? : the guide to General National Vocational Qualifications and General SVQs, the Scottish equivalent / by Windsor Chorlton.
by: Chorlton, Windsor
Published: (1994) -
Realistic adhesion test for photovoltaic modules qualification
by: Jiang Zhu, et al.
Published: (2018)